Daily Business News
Monday, November 06, 2006
  Abbott to buy Kos for $3.7 bln in cholesterol move (Reuters)

Abbott Laboratories Inc. file photo. Abbott said on Monday it will acquire Kos Pharmaceuticals Inc. for $3.7 billion to boost its presence in the lucrative cholesterol-treatment market. (Handout/Reuters)Reuters - Abbott Laboratories Inc. said on Monday it will acquire Kos Pharmaceuticals Inc. for $3.7 billion to boost its presence in the lucrative cholesterol-treatment market.


  8:07 AM
Comments: Post a Comment



<< Home
RSS :
Add to Windows Live Add to My Yahoo! Subscribe with Bloglines Add to Google XML


LINKS
PREVIOUS
PARTNER LINKS
ARCHIVES
September 2006 / October 2006 / November 2006 / December 2006 /

Powered by Blogger